These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 535184)

  • 1. The effects of protein malnutrition on the course of Leishmania mexicana infection in C57Bl/6 mice: nutrition and susceptibility to leishmaniasis.
    Pérez H; Malavé I; Arredondo B
    Clin Exp Immunol; 1979 Dec; 38(3):453-60. PubMed ID: 535184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.
    Grimaldi GF; Moriearty PL; Hoff R
    Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis.
    Scott P; Natovitz P; Sher A
    J Immunol; 1986 Aug; 137(3):1017-21. PubMed ID: 3487581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dietary protein restriction on the delayed-type hypersensitivity response to sheep red blood cells in mice.
    Malavé I; Pocino M; Baute L
    Immunology; 1983 Feb; 48(2):329-36. PubMed ID: 6822405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the host response to Leishmania mexicana.
    Pérez H
    Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis.
    Barral-Netto M; Cardoso SA; Barral A
    Acta Trop; 1987 Mar; 44(1):5-11. PubMed ID: 2884839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of C57BL/6 mice against cutaneous leishmaniosis. Kinetics of antibody synthesis and induction of cellular responses.
    Lezama-Dávila CM; Gallagher G
    In Vivo; 1995; 9(5):519-24. PubMed ID: 8900933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
    Stamm LM; Räisänen-Sokolowski A; Okano M; Russell ME; David JR; Satoskar AR
    J Immunol; 1998 Dec; 161(11):6180-8. PubMed ID: 9834104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL; Scott PA; Asofsky R; Sher FA
    J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The elevation of adoptive responses to sheep erythrocytes in protein-deficient mice.
    Price P
    Immunology; 1978 Sep; 35(3):531-7. PubMed ID: 359464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY; Singleton A; Cillari E; Howard JG
    J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Independence of the delayed hypersensitivity response from protection against Leishmania mexicana pifanoi].
    Pérez HA; De la Rora M
    Acta Cient Venez; 1986; 37(5):542-6. PubMed ID: 2966535
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice.
    Preston PM; Behbehani K; Dumonde DC
    J Clin Lab Immunol; 1978 Nov; 1(3):207-19. PubMed ID: 387961
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune response to Leishmania tropica in Macaca Mulatta.
    Wolf RE
    J Parasitol; 1976 Apr; 62(2):209-14. PubMed ID: 817009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.